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Reactive oxygen species (ROS) have been implicated in vas-
cular smooth muscle cell (VSMC) apoptosis, a hallmark of
advanced atherosclerotic lesions. Transient oxidation and
inactivation of protein-tyrosine phosphatases play a critical
role in cellular response to ROS production. However, the
function of leukocyte antigen-related (LAR) protein-tyrosine
phosphatase in ROS signaling is not known. To determine the
expression of LAR in ROS-induced apoptosis, we investigated
hydrogen peroxide-induced cell death and signaling in aortic
VSMCs fromwild-type and LAR/ mice. Histone-associated
DNA fragmentation and caspase-3/7 activity were signifi-
cantly enhanced, mitochondrial membrane integrity was
compromised, and cell viability was significantly decreased
following H2O2 treatment in LAR/ VSMCs compared with
wild-type cells. Stronger and sustained increase in autophos-
phorylation and activity of Fyn, an Src family tyrosine kinase,
was observed in LAR/ cells compared with wild-type cells
following H2O2 treatment. LAR binds to activated Fyn in
H2O2-treated VSMCs, and recombinant LAR dephosphory-
lates phosphorylated-Fyn in vitro. In addition, LAR defi-
ciency enhanced H2O2-induced phosphorylation of Janus
kinase 2 (JAK2), signal transducer and activator of transcrip-
tion 3 (STAT3), and p38 mitogen-activated protein kinase
(MAPK). PP2, a Fyn-specific inhibitor, blocked JAK2,
STAT3, and p38 MAPK activation and significantly attenu-
ated apoptosis induced by H2O2. AG490, a JAK2-specific
inhibitor, significantly attenuated H2O2-induced apoptosis,
and blocked H2O2-induced activation of STAT3, but not p38
MAPK in both wild-type and LAR/ VSMCs. Attenuation of
Fyn expression by short hairpin RNA significantly decreased
H2O2-induced downstream signaling and apoptosis in
VSMCs. Together, these data indicate that LAR regulates
Fyn/JAK2/STAT3 and Fyn/p38 MAPK pathways involved in
ROS-induced apoptosis.
Apoptosis is an essential component of normal development
as well as of most developmental abnormalities and human dis-
eases (1). Vascular smooth muscle cell (VSMC)2 apoptosis
occurs after vessel injury, in remodeling, and in advanced ath-
erosclerotic lesions (2–4). A significant increase in VSMC
death rate was observed in unstable versus stable angina
plaques, suggesting the involvement of VSMC apoptosis in
plaque rupture (5). Indeed, direct stimulation ofVSMCapopto-
sis induces destabilization and rupture of atherosclerotic
plaques (6, 7). Plaque rupture often leads to thrombosis with
clinical manifestations of myocardial infarction or stroke. Ath-
erosclerotic lesions are a highly pro-oxidant environment and
contain high levels of reactive oxygen species (ROS), which can
induce VSMC apoptosis (8–11).
In addition to atherosclerosis, ROS have been implicated
in hypertension and other vascular diseases, and intracellu-
lar signaling cascades stimulated by ROS play an important
role in the pathogenesis of these diseases. ROS-induced
stimulation of protein phosphorylation pathways modulates
transcription factor activities and gene expression, which
results in a variety of responses such as cell growth, differ-
entiation, or apoptosis (12, 13). The particular response
observed will depend on the cell type, and the concentration
and duration of ROS production.
Hydrogen peroxide, the most stable form of ROS, inhibits
protein-tyrosine phosphatases (PTPs) in vitro and reversibly
in intact cells (14–17). PTPs contain a catalytically essential
cysteine residue in their signature active site motif,
HCXXGXXR(S/T) (where X is any amino acid), with an
extremely low pKa (18). The low pKa promotes the function of
the cysteine as a nucleophile in catalysis but renders it a target
of oxidation with concomitant inhibition of PTP activity (14,
19). Recently, Groen et al. (20) reported that PTPs undergo
differential oxidation at physiological pH and H2O2 concentra-
tions, which indicates that cellular responses are fine-tuned to
various oxidative stimuli. ROS generation is the proximal event
in cell surface receptor activation by growth factors and cyto-
kines. PTPs control protein-tyrosine phosphorylation, which is
a key regulatory mechanism of many intracellular signaling
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pathways. Therefore, oxidation and inhibition of PTPs by ROS
may be an initial and critical step for ROS and growth factor-
induced signaling in cells (14, 21–23). However, very little is
known about the role of individual PTPs in regulating ROS-
induced signaling.
The mammalian leukocyte common antigen-related recep-
tor (LAR) PTP family includes LAR, PTP, and PTP (24). LAR
is expressed on the cell surface as a complex of two nonco-
valently associated subunits of 150 and 80 kDa, which are
derived by the action of an endogenous protease on a prepro-
tein (25, 26). The 150-kDa extracellular subunit comprises the
N terminus of the protein, contains three tandem immunoglob-
ulin-like domains and eight fibronectin-III like domains, and is
modified by N-linked glycosylation. The 85-kDa C-terminal
subunit contains a short ectodomain, a transmembrane
domain, and two tandem phosphatase domains: the mem-
brane-proximal D1 domain has phosphatase activity and the
distal D2 domain is catalytically inactive but may regulate sub-
strate specificity (27).
LAR has wide tissue distribution, including the lung, heart,
brain, liver, and kidney, and it is expressed in various cell lin-
eages, including epithelial cells, smooth muscle cells, and car-
diomyocytes (25, 28). Cell culture and animal model studies
have shown that this PTP acts as a negative regulator of insulin
signaling (29–31). Recently, we reported that LAR regulates
insulin-like growth factor-1 receptor signaling in VSMCs, and
dysregulation of this PTP affects vascular pathophysiology (32).
In the present study, we examined the effect of LAR on
H2O2-induced signal transduction pathways and apoptosis
using aortic VSMCs derived from LAR knockout mice. Our
results indicate that LAR regulates the viability of VSMCs
under oxidative stress conditions. Absence of LAR enhances
H2O2-inducedVSMCapoptosis, by allowing hyperactivation of
the Fyn/JAK2/STAT3 and Fyn/p38 MAPK pathways.
EXPERIMENTAL PROCEDURES
Materials—AG490, PP2, and H2O2 were purchased from
Calbiochem. A MitoCaptureTM mitochondrial apoptosis
detection kit was from BioVision. LAR enzyme was obtained
from New England Biolabs. Two distinct anti-LAR antibodies,
anti-LARmonoclonal (Cat. No. 610350, BDTransduction Lab-
oratories) and goat anti-LAR polyclonal (sc-1119, Santa Cruz
Biotechnology, Santa Cruz, CA), were used in this study. The
monoclonal antibody, raised against an epitope corresponding
to amino acids 24–194 of human LAR, recognizes 150-kDa
extracellular segment, whereas goat polyclonal antibody, raised
against an epitope in the C-terminal cytoplasmic domain of rat
LAR, recognizes the 85-kDa C-terminal subunit. The other
antibodies used were as follows: anti-Src (Tyr-416), anti-Src
(Tyr-527), anti-STAT3, anti-phospho-STAT3 (Tyr-705), anti-
ERK1/ERK2, anti-phosphospecific ERK1/2 (Thr-202 and Tyr-
204), anti-p38 MAPK, anti-phosphospecific p38 MAPK (Thr-
180/Tyr-182) and anti-phosphospecific Lck (Tyr-505) (Cell
Signaling Technology); anti-JAK2, anti-phosphospecific JAK2
(Tyr-1007 and Tyr-1008), and anti-phosphotyrosine (PY20)
(Upstate Biotechnology, Inc.); and anti-Lck and anti-Fyn (Santa
Cruz Biotechnology).
LAR-deficient Mice—LAR-deficient mice (kindly provided
by Dr. Frank Longo, University of North Carolina, Chapel Hill)
were generated by using the gene trapmethod (33, 34). LAR/
littermates were derived via heterozygous crosses and were
backcrossed at least eight times into the DBA background.
Genotyping was done using reverse transcription-PCR as
described by Yeo et al. (35).
Cell Culture—Aortic VSMCs were isolated from 4-month-
old male LAR/ and LAR/ mice as previously described by
our group (36). Cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% (v/v) fetal bovine
serum (FBS), as described previously (37). Human aortic
VSMCs (Cambrex Corp.) were cultured in smooth muscle cell
basal medium containing 5% FBS, 100 ng/ml insulin, 200 ng/ml
human fibroblast growth factor, 100 ng/ml human epidermal
growth factor, 50 g/ml gentamicin, and 50 ng/ml amphoteri-
cin. All experiments were conducted using VSMCs between
passages 4 and 11 that were growth-arrested by incubation in
DMEM containing 0.1% FBS for 72 h.
Immunoprecipitation and Western Analysis—Cells were
lysed either in radioimmune precipitation buffer (20 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 0.05 mM sodium fluoride, 1 mM
EDTA, 1% Igepal CA-630, 0.05% sodium deoxycholate, and
0.1% sodiumdodecyl sulfate) or Triton lysis buffer (20mMTris-
HCl, pH 7.4, 137 mM NaCl, 2 mM EDTA, 10% glycerol, and 1%
Triton X-100) containing protease inhibitors. Immunoprecipi-
tation and Western analysis were performed as described pre-
viously (36).
Measurement of LAR Activity—LAR activity was measured
using the fluorescence-based RediPlate 96 EnzChek Tyrosine
Phosphatase Assay Kit from Molecular Probes. VSMCs were
lysed in lysis buffer containing 20 mM Tris-Cl, pH 7.4, 132 mM
NaCl, 2 mM EDTA, 10% glycerol, 1% Triton X-100, and a pro-
tease inhibitor mixture. Cell lysates containing 500 g of pro-
tein were immunoprecipitated with goat anti-LAR polyclonal
antibody overnight at 4 °C, and then incubated with Protein
A-Sepharose beads for another 2 h. The immunoprecipitates
were washed three times with lysis buffer, and resuspended in
80 l of assay buffer (20 mMMOPS, pH 7.0, 50 mMNaCl, 1 mM
dithiothreitol, and 0.05% Tween 20) containing 50 M sub-
strate, 6,8-difluoro-4-methylumbelliferyl phosphate. The reac-
tion was performed at 37 °C for 30 min in the dark. 6,8-Dif-
luoro-4-methylumbelliferyl fluorescence was measured at an
excitationwavelength of 355 nmand an emissionwavelength of
460 nm using a WALLAC 1420 Multilabel Counter. Phospha-
tase activity was calculated using a 6,8-difluoro-4-methylum-
belliferyl phosphate standard curve.
Measurement of Recombinant LAR Activity in the Presence of
H2O2—Recombinant LAR activity was assayed by measuring
the dephosphorylation of universal phosphatase substrate,
p-nitrophenyl phosphate. Formation of p-nitrophenolate prod-
uct wasmonitored in real-time bymeasuring absorbance at 410
nm in a Beckman BDU-7500 spectrophotometer. All assays
were performed at pH 7.0 in a reaction buffer containing 25mM
MOPS, 50 mM NaCl, and 0.05% Tween 20. LAR (6.25 nM) was
reacted with 1mMH2O2 in the absence of reducing agents. The
reaction was allowed to proceed for 10min at 25 °C in the pres-
ence of 0.5 mM p-nitrophenyl phosphate.
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In Vitro Dephosphorylation Assay—Cell lysates obtained
from growth-arrested LAR/ VSMCs, treated with H2O2 for
10 min, were immunoprecipitated with either anti-Fyn or anti-
STAT3 antibodies and immobilized on protein A-agarose
beads. The beads were washed three times with lysis buffer, and
then either left untreated or incubated with purified recombi-
nant LAR (New England Biolabs), in the presence or absence of
0.1 mM sodium orthovanadate, at 30 °C. The reaction was
stoppedby addingLaemmli sample buffer andboiling for 5min.
Dephosphorylation of tyrosine-phosphorylated immunopre-
cipitates was observed by Western analysis with anti-PY20
antibody.
Construction of Recombinant Adenoviruses—Adenovirus-
encoding LAR (AdLAR) was constructed by subcloning full-
length human LAR cDNA (generously provided by Robert A.
Mooney, University of Rochester, Rochester, NY) into adeno-
viral shuttle vector, pShuttle-CMV. After homologous recom-
bination, by electroporation of pShuttle-CMV containing LAR
cDNA into BJ5183 Escherichia coli (Stratagene) possessing the
adenoviral backbone plasmid pADEasy-1, recombinants were
selected. Recombinant (E1/E3-deficient) adenoviruses were
generated by transfection of human embryonic kidney 293 cells
with the recombinant plasmid using Lipofectamine (Invitro-
gen). Then the virus was serially amplified, purified on a CsCl
density gradient by ultracentrifugation, and titered (38). A con-
trol adenovirus, consisting of the identical adenovirus back-
bone with -galactosidase cDNA insert (Ad-galactosidase),
was provided by Dr. Huang (University of North Carolina,
Chapel Hill).
Adenovirus Infection—Adenoviral infection of nearly conflu-
ent VSMCs was performed at a multiplicity of infection of 100
in DMEM containing 2% FBS. After 16-h incubation, the cells
were made quiescent in DMEM containing 0.1% FBS for 72 h.
Assessment of Apoptosis—For detection of apoptosis,
growth-arrested VSMCs were harvested after 16-h treatment
with 1 mM H2O2. Histone-associated DNA fragmentation in
cell lysates was determined using the Cell Death Detection
ELISAPLUS kit (Roche Applied Science) in accordance with the
manufacturer’s instructions.
Cell death was also assessed by staining H2O2-treated (1 mM
H2O2 for 3 h) VSMCs with MitoCapture reagent, a fluorescent
lipophilic dye that indicates loss of mitochondrial membrane
potential, which is a marker of apoptosis. MitoCapture reagent
accumulates and aggregates in the mitochondria of healthy
cells fluorescing red (590 nm), whereas in the apoptotic cells it
remains in the cytoplasm fluorescing green (530 nm). The pixel
intensity of photomicrographs obtained by fluorescent micros-
copy was quantified using ImageQuaNT software.
Determination of Cell Viability—Cell viability was measured
by using a crystal violet staining assay. Cells cultured in 96-well
plates at 8000 cells/well were treated with or without H2O2.
After 16-h treatment, the media were decanted, and the cells
were washed once with phosphate-buffered saline, followed by
crystal violet staining (0.5% crystal violet in 1% ethanol and 1.5%
formaldehyde) for 30 min. The cells were rinsed with H2O, and
the bound dye was solubilized by incubation at 37 °C for 30min
with 100 l of 1.0% deoxycholate. The absorbance was meas-
ured at 550 nm using a WALLAC 1420 Multilabel Counter.
Caspase-3/7 Assay—Caspase-3/7 activities were measured
using an Apo-ONETM Homogeneous Caspase-3/7 Assay kit
(Promega). Briefly, cells seeded in 24-well plates at a density of
2.0 104 cells/well, were grown inDMEMcontaining 10%FBS,
and then starved with serum-free medium for 24 h prior to
treatment with 1 mMH2O2 for 2 h. The cells were lysed using a
bifunctional cell lysis/activity buffer, which contained a
profluorescent caspase-3/7 consensus substrate, rhodamine
110-bis-N-CBZ-L-aspartyl-L-glutamyl-L-valyl-L-aspartic acid
amide (Z-DEVD-R110). After incubation at room temperature
for 1 h, aliquots (150 l) were transferred to a 96-well clear-
bottom plate. Fluorescence was measured at an excitation
wavelength of 485 nm and an emission wavelength of 535 nm
using a WALLAC 1420 Multilabel Counter.
Retroviral Fyn shRNAConstructs and Infection ofMouse Aor-
tic VSMCs—Two mouse pSM2 retroviral shRNAs for Fyn and
one retroviral scrambled shRNA constructs were purchased
from Open Biosystems. The sense sequences of Fyn
shRNA were 5-CCGATGTTATGTCAAAGGCCAA-3
(RMM1766-96740266) and 5-CCCACACTAACTTCCTG-
TATAA-3 (RMM1766-96740343). The scrambled shRNA
encoded a 19-bp sequence (5-GCGCGCTTTGTAGGAT-
TCG-3) with no significant homology to any mouse gene, and
was cloned into pSUPER.retro.puro vector. All retroviruseswere
prepared in [Phi]Nx-eco cells (Orbigen) by calciumphosphate trans-
fection. Puromycin-resistant clones (selected with 2g/ml puromy-
cin for 10days)were expandedprior to their use in experiments.The
effectivenessofFynshRNAwasconfirmedbyWesternblottingofcell
lysateswith anti-Fyn antibodies.
Fyn Kinase Assay—After appropriate treatments, cells were
washed with cold phosphate-buffered saline, and lysed on ice
for 15 min in lysis buffer containing 20 mM HEPES, pH 7.4, 2
mMEGTA, 1mMdithiothreitol, 50mM -glycerophosphate, 1%
Triton X-100, 10 units/ml aprotinin, 2 M leupeptin, 1 mM
Na3VO4, and 400 M phenylmethylsulfonyl fluoride. Cell
lysates containing 500 g of protein were immunoprecipitated
with anti-Fyn antibody for 2 h at 4 °C and then incubated with
40 l of 50% (w/v) protein A-Sepharose beads for an additional
1 h. The beads were washed three times with lysis buffer and
resuspended in 30 l of kinase buffer (20 mM Tris, pH 7.5, 10
mM MnCl2, 10 mM MgCl2) containing 2.5 g of denatured
human non-neuronal enolase, 5 M ATP, and 5 Ci of
[-32P]ATP and incubated at 37 °C for 15 min. The reactions
were stopped by adding 20 l of 4 Laemmli sample buffer.
The samples were heated at 95 °C for 5 min and analyzed by
SDS-gel electrophoresis on 10% acrylamide gels. The dried gel
was exposed to x-ray film and developed. Levels of phosphoryl-
ated enolase were quantified by densitometry.
Statistical Analysis—All numerical data are expressed as
mean  S.E. Data were analyzed with one-way and two-way
analysis of variance (ANOVA) and in case of one-way ANOVA,
post-hoc analysis was performed using theNewman-Keuls test.
Statistical significance was accepted at p  0.05.
RESULTS
LAR Activity Is Inhibited under Oxidative Stress Condition—
Because ROS are known to induce apoptosis by inhibiting PTP
activity (39), we investigated whether H2O2 treatment inhibits
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the activity of LAR in VSMCs. We immunoprecipitated LAR in
VSMCs lysates with an antibody raised against the C-terminal
cytoplasmic domain of LAR and measured its activity using a
TyrosinePhosphataseAssayKit (MolecularProbes).Adecreaseof
70% in LAR activity (p  0.001) was observed 5min after treat-
ment with 1 mMH2O2 (Fig. 1A). LAR activity remained inhibited
during the30-minH2O2 treatment.Wealsomeasured theeffectof
H2O2onLARactivity inLAR/VSMCsexpressingAdLAR.LAR
activity decreased significantly (p 0.001) 5min afterH2O2 treat-
ment, and a maximal inhibition of 80% was observed at 20 min
(Fig. 1B). Pretreatment with N-acetyl cysteine, a thiol-reducing
agent, abrogated H2O2-induced inhibition of LAR activity (Fig.
1C). Further, incubation of recombinant LARwith 1mMH2O2, in
the absence of reducing agents, resulted in complete inactivation
of this PTP (Fig. 1D). These data support the notion that LAR is
a redox-sensitive phosphatase, and the residual activity of this
PTP in H2O2-treated VSMCs might be due to the inherent
reducing capacity in VSMCs.
Deficiency of LAR Enhances H2O2-induced Apoptosis—ROS
are known to induce apoptosis by inhibiting PTP activity (39).
Further, H2O2-induced VSMC apoptosis is inhibited by
Na3VO4, an inhibitor of PTP (40). To investigate the role of
LAR in oxidative-stress induced apoptosis, we characterized
the effect of H2O2 on VSMC apoptosis using cells derived from
LAR/ (wild-type) and LAR/ (knockout) mice. VSMCs
were treated with 1 mM H2O2 for 16 h, and apoptosis was
assessed by analyzing histone-associated DNA fragmentation
from cellular extracts (Fig. 2A, upper panel). There was no dif-
ference in the basal level apoptosis between wild-type and LAR
knockout VSMCs. H2O2 significantly increased DNA fragmen-
tation in both wild-type and LAR knockout VSMCs compared
with their respective untreated controls. However, apoptosis in
response to H2O2 was significantly greater in LAR knockout
VSMCs compared with the wild-type VSMCs (p  0.001).
To confirm the role of LAR in H2O2-induced apoptosis, we
measured caspase-3/7 activity (Fig. 2A, middle panel), a fairly
early marker of apoptosis (41, 42). Caspase-3/7 activity levels
were very low in untreated wild-type and LAR knockout
VSMCs but increased in both cell types in response to H2O2
treatment. The observed increase in caspase-3/7 activity was
significantly greater in LAR knockout VSMCs than inwild-type
VSMCs following treatment with H2O2 for 2 h (p  0.001).
Caspase-3/7 activity wasmuch lower in both VSMCs after 16-h
treatment with H2O2. However, LAR knockout VSMCs had
significantly higher (p  0.001) caspase-3/7 activity than wild-
type cells 16 h after H2O2 treatment (data not shown). These
results indicate that deficiency of LAR results in hyperactiva-
tion of cellular signaling pathways that cause apoptosis under
oxidative stress conditions.
We further confirmed that absence of LAR enhances H2O2-
induced VSMC apoptosis by measuring changes in mitochon-
drial membrane potential using MitoCapture reagent (Fig.
FIGURE 1. H2O2 treatment inactivates LAR in mouse aortic VSMCs.
A, growth-arrested VSMCs were treated with 1 mM H2O2 for the indicated
time, and cell lysates were immunoprecipitated with anti-LAR antibody.
Phosphatase activity was measured using 6,8-difluoro-4-methylumbelliferyl
phosphate as a substrate. Data presented are mean  S.E., (n  3) of three
separate experiments (*, p  0.001 compared with control). B, LAR/ VSMCs,
infected with AdLAR, were growth-arrested and then treated with 1 mM H2O2
for the indicated times. LAR activity was measured as described above, and
data presented are mean  S.E., (n  3) and representative of three separate
experiments (*, p  0.001 compared with control). C, LAR activity was assayed
in lysates from growth-arrested VSMCs that were pretreated with 10 mM
N-acetyl cysteine for 60 min and then treated with 1 mM H2O2 for 20 min. Data
presented are mean  S.E. (n  3) of three separate experiments (*, p  0.001
compared with control). D, the catalytic activity of recombinant LAR, in the
absence of reducing agents, was assayed by monitoring the increase in
absorbance resulting from the hydrolysis of substrate, p-nitrophenyl phos-
phate. A significant change in activity was observed for time and treatment
(two-way ANOVA, p  0.0001).
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2B). VSMCs were treated with or without 1 mM H2O2 for 3 h
prior to MitoCapture staining. In untreated wild-type and
LAR knockout VSMCs, the fluorescence ofMitoCapture was
red indicating mitochondrial accumulation and healthy
cells. Following H2O2 treatment, increase in green fluores-
cence was evident in both wild-type and LAR knockout cells,
indicating apoptosis. Consistent with other markers of apo-
ptosis, the ratio of green-to-red plus green fluorescence was
significantly higher in LAR knockout VSMCs than in wild-
type VSMCs (p  0.001) (Fig. 2C).
Finally, we tested whether the increase in apoptosis after
H2O2 treatment was associated with the decrease in VSMC
viability using crystal violet staining (Fig. 2A, lower panel). Via-
bility decreased significantly in wild-type cells after H2O2 treat-
ment (p  0.01). However, cell viability was significantly lower
in LAR knockout VSMCs than in wild-type VSMCs, following
H2O2 treatment (p  0.01). Together, these data indicate that
LAR regulates the apoptotic pathways in VSMCs and plays an
important role in protecting these cells from oxidative stress-
induced death.
Deficiency of LAR Enhances H2O2-induced Tyrosine Phos-
phorylation of Fyn but Not Lck and c-Src—Berk and colleagues
(43, 44) previously demonstrated the activation of Src family
kinases in ROS-initiated signaling events. It was reported that
Fyn, a Src family kinase, is required for H2O2-mediated activa-
tion of intracellular signaling events (45). Further, it was
recently demonstrated that LAR binds both Fyn and Lck,
another Src family kinase, and that LAR dephosphorylates Fyn
both in vitro and in thymocytes (46). To determine whether
LAR deficiency has differential effects on activation of Fyn and
other Src family kinases, Lck and c-Src, we analyzed tyrosine
phosphorylation of these kinases in cellular extracts of wild-
type and LAR knockout VSMCs treatedwith 1mMH2O2. Tyro-
sine phosphorylation of Fyn and c-Src was assessed by immu-
noprecipitation of cell lysates with their respective antibodies
and then probing the immunoprecipitates with anti-phospho-
tyrosine (PY20) antibody, whereas Lck tyrosine phosphoryla-
tion was assessed by immunoblotting the cell lysates with anti-
phosphospecific Lck antibody. A significant increase in Fyn
tyrosine phosphorylation was observed with time and cell type
(p  0.0001, two-way ANOVA) in response to H2O2 treatment
(Fig. 3, A and B). Sustained increase in Lck and c-Src phospho-
rylation was observed with time in both cell types when treated
with H2O2 (p 0.0001 for each kinase, two-way ANOVA) (Fig.
3, C–F). However, there was no significant difference in tyro-
sine phosphorylation of Lck and c-Src between wild-type and
LAR knockout VSMCs (Fig. 3,D and E). It is unlikely that other
PTPs are compensating/regulating the phosphorylation of
these kinases in the absence of LAR, because LAR knockout
mice did not exhibit any changes in the expression of other LAR
family PTPs (47), and we did not observe any difference in the
activity of a related PTP, PTP1B, between LAR/ and LAR/
VSMCs (data not shown). Although we do not know the exact
mechanism, our results indicate that LAR specifically regulates
H2O2-induced Fyn, but not Lck and c-Src in VSMCs, through
tyrosine phosphorylation.
H2O2 Treatment Increases Autophosphorylation of Tyr-419
and Activity of Fyn Kinase in LAR-deficient VSMCs—Fyn con-
tains two tyrosine phosphorylation sites, Tyr-419, an autophos-
phorylation site in the tyrosine kinase domain, and Tyr-530, a
regulatory phosphorylation site within the C terminus (46).
Autophosphorylation of Tyr-419 increases kinase activity,
whereas phosphorylation of Tyr-530 inhibits the kinase via an
intramolecular interaction with the SH2 domain (48, 49). To
determine whether absence of LAR results in increased auto-
phosphorylation of Fyn in cells treated with H2O2, we immu-
noprecipitated Fyn and probed Tyr-419 phosphorylation using
phosphospecific anti-Src (pY416) antibody, which cross-reacts
with autophosphorylated Fyn kinase. Fyn autophosphorylation
increased significantly, but transiently 5 min after H2O2 treat-
ment (p  0.05 versus respective control) in wild-type VSMCs
(Fig. 4A). However, the absence of LAR caused significant and
sustained increase in autophosphorylation of Fyn in VSMCs
treated with H2O2 (p  0.001 versus untreated LAR knockout
VSMCs and wild-type VSMCs following H2O2 treatment).
Next, we examined the effect of H2O2 on phosphorylation of
Fyn Tyr-530 by immunoprecipitating the VSMC lysates with
anti-Fyn antibody, followed by Western analysis with phos-
phospecific anti-Src (pY527) antibody, which cross-reacts with
phosphorylated Fyn Tyr-530. Consistent with the report of
Sanguinetti et al. (49), H2O2 treatment of wild-type VSMCs
increased phosphorylation of Fyn on its inhibitory Tyr residue
in the C terminus (p 0.05 at 5min versus untreated cells) (Fig.
4B). Phosphorylation of Fyn Tyr-530 was significantly higher in
LAR/ VSMCs than in wild-type VSMCs 10, 20, and 30 min
after H2O2 treatment (p  0.001 for each time point).
FIGURE 2. LAR deficiency increases H2O2-induced apoptosis and caspase-
3/7 activity, and decreases cell viability in VSMCs. A, growth-arrested
VSMCs were treated with 1 mM H2O2 for 16 and 2 h, and lysates were used to
measure histone-associated DNA fragmentation (upper panel) and caspase-
3/7 activity (middle panel), respectively. Viability of VSMCs treated with 1 mM
H2O2 for 16 h was assayed by staining with crystal violet (lower panel). The
absorbance was measured at 550 nm, and cell survival data are expressed as
percent of untreated cells (mean  S.E., n  3; *, p  0.01 compared with
LAR/ VSMCs treated with H2O2). B, H2O2-induced apoptosis as measured
by mitochondrial membrane injury. VSMCs were either untreated or treated
with 1 mM H2O2 for 3 h, and then stained with MitoCapture reagent and
visualized using a fluorescence microscope. Predominant red staining is
indicative of healthy cells, whereas predominant green staining indicates
apoptotic cells. C, pixel intensity of MitoCapture-treated LAR/ and LAR/
cells was determined, and the data are presented as the ratio of green to red
plus green pixel intensity (mean  S.E., n  3; *, p  0.001 compared with
wild-type cells treated with H2O2).
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Because LARdeficiency resulted in increase in both the auto-
phosphorylation as well as phosphorylation of inhibitory Fyn
Tyr-530 residue, we measured Fyn activity in untreated and
β
FIGURE 3. LAR deficiency increases tyrosine phosphorylation of Fyn.
A, VSMCs were either left untreated or treated with 1 mM H2O2, and the cell
lysates containing equal amounts of protein were immunoprecipitated with
anti-Fyn antibody followed by Western analysis with either anti-phosphoty-
rosine (PY20) antibody or anti-Fyn antibody. Cell lysates were also analyzed by
Western blotting with anti-LAR monoclonal antibody, and the membrane was
reprobed with anti--actin antibody. B, densitometric analysis of normalized Fyn
phosphorylation (mean  S.E., n  3; p  0.0001 for cell type and time in two-way
ANOVA).C, VSMCswerestimulatedwith1mMH2O2,andcelllysateswereanalyzedby
Western blotting with either anti-phospho Lck or anti-Lck antibody. D, densitometric
analysis of normalized Lck phosphorylation (meanS.E., n 3; p  0.0001 for time
in two-way ANOVA). E, H2O2-treated VSMC lysates were immunoprecipitated
with anti-c-Src antibody followed by Western analysis with either anti-PY20 anti-
body or anti-c-Src antibody. F, densitometric analysis of normalized c-Src phos-
phorylation (mean  S.E., n  3; p  0.0001 for time in two-way ANOVA).
FIGURE 4. H2O2-induced Fyn autophosphorylation and kinase activity are
enhanced in the absence of LAR. A, growth-arrested LAR/ and LAR/
VSMCs were either left untreated or treated with 1 mM H2O2 for the indicated
times, and the cell lysates were immunoprecipitated with anti-Fyn antibody
followed by Western analysis with anti-phosphospecific Fyn (pY419) anti-
body (top panel). The membrane was reprobed with anti-Fyn antibody (mid-
dle panel). Densitometric analysis (lower panel) of Fyn autophosphorylation
(mean  S.E., n  3; *, p  0.05 versus untreated LAR/ VSMCs, **, p  0.01
versus respective control, ***, p  0.001 versus respective control). B, lysates
from VSMCs, treated as described above, were immunoprecipitated with
anti-Fyn antibody followed by Western analysis with anti-phosphospecific
Fyn (pY530) antibody (top panel). The membrane was reprobed with anti-Fyn
antibody (middle panel). Densitometric analysis (lower panel) of Fyn (pY530)
phosphorylation (mean  S.E., n  3; *, p  0.05 versus untreated LAR/
VSMCs, **, p  0.001 versus respective control). C, growth-arrested VSMCs
were treated with 1 mM H2O2 for the indicated times. Cell lysates containing
equal amount of protein were immunoprecipitated with anti-Fyn antibody,
and Fyn kinase activity was measured by an immunocomplex kinase assay
using denatured enolase as the substrate (top panel). Densitometric analysis
(lower panel) of Fyn activity (mean  S.E., n  3; *, p  0.05 versus untreated
LAR/ VSMCs; ** p  0.05 versus respective control; ***, p  0.05 versus
respective control; #, p  0.001 versus respective control).
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H2O2-treated VSMCs using an
immunocomplex kinase assay with
enolase as the substrate. Fyn kinase
activity, after H2O2 treatment,
increased significantly in wild-type
VSMCs for 10 min (p  0.05 versus
untreated control) (Fig. 4C). How-
ever, the activity of Fyn kinase
decreased thereafter and returned
to near basal levels 30 min after
H2O2 treatment. Fyn kinase activity
in LAR knockout VSMCs was sig-
nificantly higher under basal condi-
tions (p 0.05 versusuntreatedwild
type) and increased further with
H2O2 treatment (p  0.05 30 min
after treatment versus untreated
LAR knockout VSMCs). Deficiency
of LAR resulted in significant and
sustained activation of Fyn kinase
after H2O2 treatment (p  0.001
versus wild-type VSMCs 30 min
after H2O2 treatment). Together,
these data indicate that increase in
autophosphorylation overrides the
increase in phosphorylation of
inhibitory Tyr-530 residue in mod-
ulating Fyn activity in the absence of
LAR.
Enhanced Activation of JAK2-STAT3 Pathway and p38
MAPK in H2O2-treated LAR-deficient VSMCs—Fyn is
required forH2O2-mediated activation of Janus kinase 2 (JAK2)
(43), which is essential forH2O2-induced apoptosis (50). There-
fore, we investigated whether sustained activation of Fyn by
H2O2 in LARknockout cells would result in higher activation of
JAK2 aswell.Western analysis with phosphospecific antibodies
demonstrated a significant increase in JAK2 phosphorylation
with time and cell type in VSMCs treated with H2O2 (p 
0.0001, two-way ANOVA) (Fig. 5, A and B). To determine
whether enhanced activation of JAK2 in LAR knockout VSMCs
treatedwithH2O2 leads to tyrosine phosphorylation of STAT3,
a JAK2 substrate, we measured STAT3 tyrosine phosphoryla-
tion in wild-type and LAR knockout VSMCs treated with H2O2
(Fig. 5C). H2O2 treatment caused a significant increase in
STAT3 tyrosine phosphorylation with time and cell type (p 
0.0001, two-way ANOVA) in VSMCs (Fig. 5D).
Fyn tyrosine kinase is upstream of p38 MAPK in the signal
transduction pathways of several cells, including vascular cells
(51, 52). Because the activation of p38 MAPK has been impli-
cated in apoptosis of VSMCs (53, 54), we examined the activa-
tion of this kinase in wild-type and LAR knockout VSMCs
treatedwithH2O2 (Fig. 5E). Phosphorylation of p38MAPKwas
significantly higher in LAR knockout VSMCs than in wild-type
cells 5 (p  0.01), 10 (p  0.001), and 20 min (p  0.05) after
H2O2 treatment (Fig. 5F).
LAR Binds to and Dephosphorylates Activated Fyn—Because
Fyn kinase tyrosine phosphorylation was increased in LAR
knockout VSMCs and LARwas shown to bind Fyn in other cell
FIGURE 5. JAK2, STAT3, and p38 MAPK phosphorylation are enhanced in the absence of LAR. Growth-arrested
LAR/ and LAR/ VSMCs were either left untreated or treated with 1 mM H2O2, and phosphorylation was deter-
mined by immunoblotting with either anti-phospho JAK2 (A), anti-phospho STAT3 (C), or anti-phospho p38 MAPK
(E) antibodies. Densitometric analysis of normalized phospho JAK2 (B), phospho STAT3 (D), and phospho p38 MAPK
(F) (mean  S.E., n  3; *, p  0.01, **, p  0.001, and ***, p  0.05 versus respective controls).
FIGURE 6. LAR associates with and dephosphorylates activated Fyn. A, lysates
from growth-arrested LAR/ VSMCs, either untreated or treated with 1 mM
H2O2 in the presence of Ad-galactosidase or AdLAR, were immunoprecipitated
with anti-Fyn antibody and Western analysis was performed with anti-LAR anti-
body. The membrane was reprobed with anti-Fyn antibody. LAR overexpression
was confirmed by Western analysis of cell lysates with either anti-LAR or anti--
actin antibody (loading control). B, growth-arrested LAR/ VSMCs infected with
AdLAR were treated with H2O2, and cell lysates were immunoprecipitated with
either anti-Fyn or anti-LAR antibodies or isotype-matched control antibodies.
Western analysis was done with either anti-LAR (the membrane was reprobed
with anti-Fyn) or anti-Fyn (membrane reprobed with anti-LAR) antibodies. LAR
overexpression was confirmed as described above. C, Fyn or STAT3 were immu-
noprecipitated from lysates of VSMCs treated with H2O2, immobilized on protein
A-agarose beads, and incubated with recombinant LAR in the phosphatase reaction
buffer. Phosphorylation was examined with either anti-PY20 or anti-phospho STAT3
(Tyr-705) antibodies. Equal loading of Fyn and STAT3 in cell lysates was confirmed by
immunoprecipitation/Western analysis of aliquots with respective antibodies.
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types (46), we investigated whether the regulatory function of
LAR on Fyn is mediated by a direct physical interaction
between the two proteins in VSMCs treated with H2O2. LAR
knockout VSMCs, infected with either human AdLAR or Ad-
galactosidase, were treated with or without H2O2 for 10 min.
Immunoprecipitation of these cell lysates with anti-Fyn anti-
body followed by Western analysis with anti-LAR C-terminal
antibody revealed enhanced association of LAR with activated
Fyn kinase in VSMCs following treatment with H2O2 (Fig. 6A).
The association of LAR with activated Fyn was corroborated
using lysates from LAR knockout VSMCs infected with human
AdLAR and treated with H2O2. Immunoprecipitation of cell
lysates with anti-Fyn antibody followed by Western analysis
with anti-LAR C-terminal antibody and reciprocal immuno-
precipitation with anti-LAR C-terminal antibody andWestern
analysis with Fyn antibody confirmed enhanced association of
LAR with activated Fyn (Fig. 6B).
Next we examined whether LAR dephosphorylates Fyn in
vitro. LAR knockout VSMCs were treated with H2O2 for 10
min, and activated Fyn in the lysates
was immunoprecipitated with anti-
Fyn antibody and incubated with
purified recombinant LAR (New
England Biolabs) or vehicle. As
shown in Fig. 6C (upper panel),
Western analysis of immunopre-
cipitates with anti-PY20 antibody
indicated that recombinant LAR
dephosphorylated Fyn in a time-
dependent manner. Fyn tyrosine
dephosphorylation by LAR was
inhibited in the presence of sodium
vanadate, a potent inhibitor of PTP.
In contrast, LAR did not dephos-
phorylate activated STAT3 immu-
noprecipitated from LAR knockout
VSMCs treated with H2O2 (Fig. 6C,
lower two panels). Taken together,
these results suggest that activated
Fyn is a possible substrate of LAR in
vivo under oxidative stress condi-
tions. Furthermore, LAR mainly
regulates the activity of Fyn kinase
by modulating autophosphoryla-
tion of Tyr-419 in the kinase
domain.
Src Family-selective Tyrosine
Kinase Antagonist PP2 Inhibits
H2O2-induced JAK2, STAT3, and
p38 MAPK Phosphorylation—Be-
cause Fyn has been suggested to be
upstream of JAK2 and p38 MAPK
(43, 51, 52), we investigatedwhether
Fyn activation is required for H2O2-
induced stimulation of JAK2,
STAT3, and p38MAPKs in VSMCs
(Fig. 7). Pretreatment of VSMCs
with 1 M PP2 abrogated H2O2-in-
duced tyrosine phosphorylation of Fyn in wild-type VSMCs
(p  0.05 versus H2O2 treatment for 10 min, Fig. 7, A and B).
H2O2-induced Fyn tyrosine phosphorylation in LAR/
VSMCs was also significantly (p  0.001 versus H2O2 treat-
ment for 10 min) inhibited by PP2 pretreatment. Similarly,
complete inhibition of H2O2-induced tyrosine phosphoryla-
tion of JAK2 was observed with PP2 pretreatment in both
wild-type (p  0.05 versus H2O2 treatment for 10 min) and
LAR knockout VSMCs (p  0.001 versusH2O2 treatment for
10 min, Fig. 7, C and D). Consistent with the inhibition of
JAK2 activation, PP2 pretreatment significantly decreased
H2O2-induced STAT3 tyrosine phosphorylation in both
wild-type and LAR/ VSMCs (p  0.001 versusH2O2 treat-
ment for 10 min for both the cell types) (Fig. 7, E and F). PP2
pretreatment also significantly inhibited H2O2-induced
phosphorylation of p38 MAPK in both wild-type and
LAR/ VSMCs (p  0.001 versus H2O2 treatment for 10
min for both the cell types) (Fig. 7, G and H). These data
indicate that Fyn activation regulates H2O2-induced signal-
FIGURE 7. H2O2-induced Fyn and JAK-STAT pathway and p38 MAPK activation is abrogated by a Fyn
inhibitor. Growth-arrested VSMCs were pretreated with DMSO or PP2 (1 M) for 2 h before treatment with 1
mM H2O2 for the indicated times. Lysates were immunoprecipitated with anti-Fyn antibody and subjected to
Western analysis with anti-PY20 antibody (A). Lysates were subjected to Western analysis with either anti-
phospho Jak2 (C), anti-phospho STAT3 (E), or anti-phospho p38 MAPK (G) antibodies. Densitometric analysis of
normalized phospho Fyn (B), phospho JAK2 (D), and phospho STAT3 (F) and phospho p38 MAPK (H) (mean 
S.E., n  3; *, p  0.05, and **, p  0.001 versus respective cells treated with H2O2 for 10 min).
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ing events, and Fyn is an upstream kinase in the JAK-STAT
pathway and p38 MAPK activation.
Silencing of Fyn Expression by shRNA Abrogates H2O2-in-
duced JAK2, STAT3, and p38 MAPK Phosphorylation in
VSMCs—Toconfirm the requirement for Fyn inH2O2-induced
JAK2, STAT3, and p38 MAPK activation, we used retroviral
expression of Fyn shRNAmir to silence the expression of the
endogenous Fyn. Infection of wild-type and LAR/ VSMCs
with retroviral Fyn shRNA construct decreased Fyn expression
by70%comparedwith respective scrambled shRNA-express-
ing VSMCs (Fig. 8A). Expression of Fyn shRNA abrogated
H2O2-induced increase in JAK2 phosphorylation in wild-type
(p  0.01 versus respective scrambled shRNA-expressing cells
treated with H2O2 for 10 min) and LAR/ VSMCs (p  0.001
versus respective scrambled shRNA-expressing cells treated
with H2O2 for 10 min) (Fig. 8, B and C). Consistent with JAK2
inhibition, Fyn shRNA expression inhibited H2O2-induced
increase in STAT3 phosphorylation in wild-type (p  0.05 ver-
sus respective scrambled shRNA-expressing cells treated with
H2O2 for 10 min) and LAR/ VSMCs (p  0.001 versus
respective scrambled shRNA-ex-
pressing cells treated with H2O2 for
10min) (Fig. 8,D and E). Expression
of Fyn shRNA also significantly
decreased H2O2-induced increase
in p38 MAPK phosphorylation in
wild-type (p  0.001 versus
respective scrambled shRNA-ex-
pressing cells treated with H2O2
for 10 min) and LAR/ VSMCs
(p  0.001 versus respective scram-
bled shRNA-expressing cells treated
with H2O2 for 10 min) (Fig. 8, F and
G). However, expression of Fyn
shRNA had no effect on the steady-
state levels of JAK2, STAT3, and p38
MAPK expression. Together, these
data indicate that LAR regulates
H2O2-induced cell signaling in
VSMCs by modulating Fyn
activation.
JAK2 Activates STAT3, but Not
p38 MAPK, in VSMCs Treated with
H2O2—Todeterminewhether JAK2
is upstream of STAT3 as well as p38
MAPK activation, we investigated
the effect of AG490, a JAK2-specific
inhibitor, on the activation of
STAT3 and p38MAPK in wild-type
and LAR knockout VSMCs treated
with H2O2. Pretreatment with 25
M AG490 for 16 h prior to H2O2
treatment had no effect on phos-
phorylation of Fyn, the JAK2
upstream kinase, in wild-type and
LAR/ cells (Fig. 9, A and B). Pre-
treatment with AG490 significantly
inhibited H2O2-induced tyrosine
phosphorylation of JAK2 in both wild-type (p  0.05 versus
respective cells treated with H2O2 for 10 min) and LAR knock-
out (p  0.001 versus respective cells treated with H2O2 for 10
min) VSMCs (Fig. 9,C andD). Consistent with the inhibition of
JAK2 stimulation, STAT3 tyrosine phosphorylation was signifi-
cantly inhibited in both wild-type (p 0.05 versus respective cells
treated with H2O2 for 10min) and LAR knockout (p 0.001 ver-
sus respectiveH2O2-treated cells)VSMCs (Fig. 9,E andF). In con-
trast, p38 MAPK phosphorylation induced by H2O2 was unaf-
fected by AG490 in both the cell types (Fig. 9, G and H). These
results indicate thatLARregulates twoalternativeoxidative stress-
induced pathways in VSMCs: a Fyn/JAK2/STAT3 pathway and a
Fyn/p38MAPK pathway.
Fyn and JAK2 Are Required for H2O2-induced Apoptosis of
VSMCs—To elucidate the role of Fyn activation in H2O2-in-
duced VSMC apoptosis, we pretreated wild-type and LAR
knockout VSMCswith Fyn inhibitor PP2 (1M) for 2 h, prior to
treatment with or without H2O2 for 16 h (Fig. 10A). PP2 pre-
treatment significantly decreased H2O2-induced apoptosis, as
measured by histone-associated DNA fragmentation, in both
FIGURE 8. H2O2-stimulated tyrosine phosphorylation of JAK2 and STAT3 and p38 MAPK are inhibited in
Fyn shRNA-expressing LAR/ and LAR/ VSMC clones. Scrambled shRNA- or Fyn shRNA-expressing
LAR/ and LAR/ VSMCs lysates were analyzed by Western analysis with anti-Fyn antibody, and the mem-
brane was reprobed with anti--actin antibody (A). Scrambled shRNA- or Fyn shRNA-expressing LAR/ and
LAR/ VSMCs clones were growth-arrested and then treated with 1 mM H2O2 for the time indicated, and
lysates were analyzed by Western blotting with either anti-phospho JAK2 (B), anti-phospho STAT3 (D), or
anti-phospho p38 MAPK (F) antibodies. Densitometric analysis of normalized phospho JAK2 (C), phospho
STAT3 (E), and phospho p38 MAPK (G) (mean  S.E., n  3; *, p  0.01, **, p  0.001 and ***, p  0.05 versus
respective cells treated H2O2 for 10 min).
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wild-type and LAR knockout VSMCs (p  0.001 versus respec-
tive cells treated with H2O2).
Consistentwith the effect of PP2 onH2O2-induced apoptosis
in VSMCs, histone-associated DNA fragmentation upon H2O2
treatment was partially, but significantly decreased in wild-
type VSMCs clones expressing Fyn shRNA compared with
untreated wild-type cells or scrambled shRNA-expressing
wild-type VSMCs clones (p  0.01) (Fig. 10B). Similarly, a
significant decrease in histone-associated DNA fragmentation
upon H2O2 treatment was observed in LAR knockout VSMCs
clones expressing Fyn shRNA compared with H2O2-treated LAR
knockoutVSMCsor scrambled shRNAexpressingLARknockout
VSMCs clones (p  0.001). Importantly, suppression of Fyn
expression in LAR knockout VSMCs decreased H2O2-in-
duced histone-associatedDNA fragmentation to the same level
observed in wild-type VSMCs clones expressing Fyn shRNA.
Together, these results indicate that
LAR regulates H2O2-induced apo-
ptosis by modulating Fyn kinase
activity.
Similar to the effect of PP2 on
H2O2-induced apoptosis, pretreat-
ment of VSMCs with 25 M AG490
for 16 h significantly decreased
H2O2-induced histone-associated
DNA fragmentation in wild-type
and LAR knockout VSMCs (p 
0.001 versus respective cells treated
with H2O2) (Fig. 10C). Overall,
these results suggest that LAR
regulates VSMC apoptosis under
oxidative stress conditions by
inhibiting hyperactivation of Fyn/
JAK2/STAT3 and Fyn/p38 MAPK
pathways.
LAR Overexpression Attenuates
H2O2-induced Fyn Activation in
LAR-deficient VSMCs—To confirm
the regulatory role of LAR in Fyn
activation induced by H2O2, LAR
knockout VSMCs were infected
with either Ad-galactosidase or
AdLAR and then treated with
H2O2. As shown in Fig. 11, overex-
pression of LAR in LAR knockout
VSMCs led to enhanced associa-
tion of LAR with activated Fyn
(top panel) and decreased tyrosine
phosphorylation of Fyn kinase
(second panel). Increased associa-
tion of LAR with Fyn and
decreased phosphorylation of Fyn
were also observed in human aor-
tic SMC overexpressing LAR and
treated with H2O2 (data not
shown). Together, these results
support the notion that LAR regu-
lates Fyn activity in VSMCs under
oxidative stress conditions.
DISCUSSION
ROS regulate various redox-sensitive cellular functions,
including response to stress or growth signals (55). H2O2 is
produced during activation of cognate receptors by various
growth factors, cytokines, and hormones. The transient
increase in intracellularH2O2 produced under these conditions
is equivalent to exogenously added H2O2 concentrations of
0.1–1.0 mM (22, 56). When H2O2 is applied to cell cultures, a
rapid equilibrium is established, from the metabolic actions
of cellular peroxidases and catalases, in which the intracel-
lular concentration of H2O2 is 7- to 10-fold less than the
extracellular concentration (56). PTPs are the important
redox sensors inside the cell, because localized reversible
oxidation and consequent inactivation of these proteins
FIGURE 9. H2O2-stimulated tyrosine phosphorylation of JAK2 and STAT3 but not Fyn and p38 MAPK are
inhibited by AG490 in both LAR/ and LAR/ VSMCs. Growth-arrested VSMCs were pretreated with 25
M AG490 for 16 h and then treated with H2O2 for 10 min. Cell lysates were immunoprecipitated with anti-Fyn
antibody followed by Western analysis with anti-phosphotyrosine (PY20) or anti-Fyn antibody (A). Cell lysates
were also analyzed by Western blotting with either anti-phospho JAK2 (C), anti-phospho STAT3 (E), or anti-
phospho p38 MAPK (G) antibodies. Densitometric analysis of normalized phospho Fyn (B), JAK2 (D), phospho
STAT3 (F) and phospho p38 MAPK (H) (mean  S.E., n  3, *, p  0.05, **, p  0.001 and ***, p  0.05 versus
respective cells treated with H2O2).
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ensures efficient intracellular sig-
nal propagation (14, 16, 57). ROS-
induced inactivation of PTPs in
VSMCs was reported (58, 59),
however, the specific role of indi-
vidual PTP in regulating apoptotic
pathways has not yet been investi-
gated. In the present report, we char-
acterize the role of LAR in H2O2-in-
duced apoptosis using VSMCs
derived from mice that are deficient
in this PTP. Our data indicate that
LAR plays an important role in
VSMC survival by negatively regulat-
ingH2O2-induced Fyn activation and
downstream effector pathways of
apoptosis.
Our results demonstrate that
LAR is inactivated rapidly in
VSMCs treated with H2O2. This is
consistent with the report of Groen
et al. (20), which demonstrated that
both catalytically active membrane-
proximal domain D1 and mem-
brane-distal regulatory domain D2
of LAR are readily oxidized at low
H2O2 concentrations, withmaximal
oxidation at 125–250 M concen-
tration. However, VSMCs contain
several other redox-sensitive PTPs
such as SHP-1, PTP1B, and low
molecular weight PTP (13), which
might become inactive at the H2O2
concentration we used in this study.
The use of LAR-deficient VSMCs
allowed us to circumvent the con-
founding effects of other inactivated
PTPs followingH2O2 treatment and
investigate the specific role of LAR
in regulating stress-induced apop-
totic pathways. Our results show
that activation of Fyn in response to
H2O2 treatment is transient in wild-
type VSMCs, whereas absence of
LAR results in sustained activation
of this proapoptotic kinase inH2O2-
treated cells (Fig. 4).
The critical role of Fyn activation
in redox-sensitive mechanisms is
evident from the impaired ROS-in-
duced cellular signaling pathways in
various Fyn knockout cells (43, 45).
Further, caspase activation and
DNA fragmentation induced by
various proapoptotic stimuli are sig-
nificantly reduced in embryonic
fibroblasts and thymocytes from
Fyn knockout mice (60), which
FIGURE 10. H2O2-induced apoptosis in wild-type and LAR
/ VSMCs is inhibited by PP2, expression of Fyn
shRNA, and AG 490. A, growth-arrested VSMCs were pretreated with 1 M PP2 for 2 h and then treated with 1 mM
H2O2 for 16 h. Cell lysates were assayed for histone-associated DNA fragmentation (mean  S.E., n  3; *, p  0.001
respective H2O2-treated cells). B, mock-infected control VSMCs, scrambled shRNA- or Fyn shRNA-expressing LAR
/
and LAR/ VSMCs clones were growth-arrested and then treated with 1 mM H2O2 for 16 h. Cell lysates were assayed
for histone-associated DNA fragmentation (mean  S.E., n  3; *, p  0.01 versus mock-infected H2O2-treated
LAR/ VSMCs; **, p  0.001 versus mock-infected H2O2-treated LAR
/ VSMCs). C, growth-arrested VSMCs were
pretreated with 25 M AG490 for 16 h and then treated with 1 mM H2O2 for 16 h. Cell lysates were assayed for
histone-associated DNA fragmentation (mean  S.E., n  3; *, p  0.001 respective H2O2-treated cells).
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strengthens the idea that Fyn activation is a critical event in
stress-induced apoptosis. These observations are in agreement
with our data that silencing of Fyn expression by shRNA signif-
icantly attenuated H2O2-induced downstream signaling path-
ways (Fig. 8) and apoptosis in bothwild-type andLARknockout
VSMCs (Fig. 10).
Regulation of Src-family kinase activity occurs throughphos-
phorylation on two tyrosine residues (48). Autophosphoryla-
tion of tyrosine in the activation loop (Tyr-419 in Fyn) increases
kinase activity, whereas phosphorylation of tyrosine residue in
the C terminus (Tyr-530 in Fyn) inhibits activity through an
intramolecular SH2 (Src homology 2)-phosphotyrosine inter-
action. It has been suggested that dephosphorylation of tyro-
sine in the C-terminal domain precedes the autophosphoryla-
tion of tyrosine in the activation loop for full kinase activity (61).
However, Sanguinetti et al. (49) demonstrated that, concomi-
tant with autophosphorylation, oxidative stress also increased
phosphorylation of the inhibitory site of Fyn, which indicates
that activation of Fyn is rapidly followed by inactivation. Acti-
vation of Fyn could also be regulated by LAR as this activated
PTP is associated with Fyn and dephosphorylates the phospho-
tyrosine residues in both the kinase domain and C terminus
(46). Consistent with these observations, our results demon-
strate enhanced association of LARwith activated Fyn inH2O2-
treated VSMCs (Fig. 5, A and B) and increased autophospho-
rylation and sustained activation of Fyn in LAR knockout
VSMCs treated with H2O2. This occurred despite increased
phosphorylation of Tyr-530 in Fyn. Furthermore, absence of
LAR impaired mitochondrial membrane potential in VSMCs
treated with H2O2 and enhanced caspase-3/7 activity and apo-
ptosis (Fig. 2).
Our data indicate increased activation of JAK2 and STAT3 in
wild-type VSMCs and significantly enhanced activation of
these proteins in LAR knockout VSMCs compared with wild-
type cells in response toH2O2 treatment. In addition, inhibition
of Fyn activity with PP2 pretreatment abrogatedH2O2-induced
JAK2 and STAT3 stimulation in both wild-type and LAR
knockout mice. These data are in consonance with the obser-
vations that H2O2-stimulated JAK2 activity was completely
inhibited in Fyn knockout cells (43)
and that Fyn directly interacts with
activated JAK2 (62).
The JAK2-specific inhibitor,
AG490, not only abrogated H2O2-
induced stimulation of STAT3 (Fig.
8, C and D), but also significantly
attenuatedH2O2-induced apoptosis
in both wild-type and LAR knock-
out cells (Fig. 9B). These results are
in agreement with the observation
of Sandberg and Sayeski (50) that
activation of JAK2 is essential for
H2O2-induced apoptosis of VSMCs.
They have shown that JAK2 activa-
tion leads to induction of proapo-
ptotic Bax expression, impaired
mitochondrial membrane integrity,
and activation of caspases. Further,
AG490 treatment markedly reduced ischemia-induced infarct
size and cardiomyocyte apoptosis (63). Although STAT3 activa-
tion is usually associatedwith cell proliferation, strong and pro-
longed activation of STAT3 induces apoptosis (64, 65), which
further supports our conclusions that hyperactivation of the
Fyn/JAK2/STAT3 pathway in the absence of LAR induces
VSMC apoptosis.
Our data indicate that H2O2-induced p38 MAPK activity,
which was increased in wild-type VSMCs, was further
enhanced in the absence of LAR. PP2 pretreatment abrogated
H2O2-induced p38 MAPK activity, whereas AG490 had no
such inhibitory effect. These data confirm that Fyn is upstream
of p38 MAPK activation (51, 52) and that Fyn/JAK2/STAT3
and Fyn/p38 MAPK are two distinct signaling pathways
involved in oxidative stress-induced VSMC apoptosis. It is well
documented that p38 MAPK plays a critical role in apoptosis
induced by several agonists (54, 66, 67). Phosphorylation of
Bcl-2 by activated p38 MAPK in mitochondrial compartment
leads to cytochrome c release and caspase activation, and these
processes are absent in p38 MAPK-deficient cells (68).
In conclusion, our results demonstrate that LAR is a redox-
sensor and negative regulator of H2O2-induced apoptosis in
VSMCs. Moreover, our report elucidates Fyn/JAK2/STAT3
and Fyn/p38 MAPK pathways as intracellular mediators of
H2O2-induced VSMC apoptosis. Our data also suggest tissue/
cell-specific effect of LAR as its activation/expression was cor-
related with increased apoptosis in other tissues (69–71). PTP
inhibitor development is an active area of research for the treat-
ment of obesity and diabetes. However, our data cautions on
the use of such a strategy, because apoptosis, induced by exac-
erbated oxidative stress prevalent under such pathophysiolog-
ical conditions, may profoundly affect many vascular diseases.
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